Australian Clinical Labs Ltd (AU:ACL) has released an update. Australian Clinical Labs Ltd has announced a daily buy-back of its ordinary fully paid securities, with 115,757 shares bought back on the ...

Mobix Labs (Nasdaq: MOBX), a leader in advanced connectivity ... at 08:10 ICON plc to Present at the Jefferies London Healthcare Conference ICON plc, a world-leading healthcare intelligence and ...

Key research directions emerging from his lab raise intriguing questions about the future of ... "The fact that we will soon ...

To better understand why some cancer patients struggle to fight off infections, Georgia Tech researchers have created tiny ...

Despite positive trial data, Sarepta Therapeutics has decided to stop the clinical development of SRP-5051 (vesleteplirsen ..

"Additionally, the ReliaPreptm kits cater to labs requiring adaptable solutions ... upcoming healthcare conferences and participating in... ICON plc, a world-leading healthcare intelligence and ...

Their project will investigate treatments that may stop toxic astrocytes from forming in lab and animal models of MS ... that ...

Clinical research suggests a common chemical in the supplements could lead to the onset of Alzheimer's disease ...

J.P. Morgan analyst Casey Woodring maintained a Hold rating on Charles River Labs (CRL – Research Report) on November 6 and set a price ...

Collin College is planning a new building at its Frisco campus that will serve as the hub for health sciences programs in the ...